Clinical trial
Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic…
NCT00389103 · Sanofi Pasteur, a Sanofi Company, Industry · Withdrawn
Key facts
| NCT number | NCT00389103 |
|---|---|
| Title | Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) |
| Official title | A Phase 1, Placebo-Controlled, Double-Blind Study of the Safety and Immunogenicity of Two Injections of MVA3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Vaccinia Naive Adult Subjects With a History of Atopic Dermatitis (AD) |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Smallpox, Atopic Dermatitis |
| Intervention type | Biological |
| Interventions | MVA (smallpox vaccine) |
| Enrollment | 0 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Oct 18, 2006 |
| Last update posted | Jan 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: